🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Venous Thromboembolic Events (ETVs) are the second leading cause of death (...
Status
Unknown
Location
Ambroise Pare Hospital
Start Date
2019-07-01
Trial ID
NCT04294589
The proposed study will address the critical need to reduce illegal drug us...
Status
Completed
Location
UCLA
Start Date
2011-01
Trial ID
NCT01942876
Treatments Being Tested
Drug therapy for patients suffering from autonomic failure and neurogenic o...
Status
Completed
Location
Dysautonomic Center at NYU Langone Medical Center
Start Date
2016-08-29
Trial ID
NCT02784535
Treatments Being Tested
Numerous studies describe HRQoL in other cancer types, whereas only sparse ...
Status
Unknown
Location
Gitte Dam
Start Date
2020-09-01
Trial ID
NCT04557137
Treatments Being Tested
This pilot study is a non-randomized controlled cohort study evaluating the...
Status
Completed
Location
Ekialo Kiona Center
Start Date
2011-11
Trial ID
NCT01912521
Treatments Being Tested
Evaluation of a short version of Narrative Exposure Therapy...
Status
Completed
Location
University of Konstanz
Start Date
2012-10
Trial ID
NCT01720732
Treatments Being Tested
Critically ill patients with acute kidney injury and fluid overload who are...
Status
Terminated
Location
Mayo Clinic
Start Date
2022-07-05
Trial ID
NCT05306964
Treatments Being Tested
This is a prospective, open-label, multi-center, non-comparative, non-inter...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-05-10
Trial ID
NCT04946305
Treatments Being Tested
The purpose of this study is to compare the efficacy and cost-effectiveness...
Status
Completed
Location
Kabale District Health Services (antenatal clinics at selected sites)
Start Date
2004-01
Trial ID
NCT00142207
The purpose of this study is to evaluate incidence of grade 4 neutropenia i...
Status
Completed
Location
Pfizer New York
Start Date
2024-08-19
Trial ID
NCT05912933